Skip to content

Diagnostic Value of D-dimer/Fibrinogen Ratio in Patients With Acute Aortic Dissection

Diagnostic Value of D-dimer/Fibrinogen Ratio in Patients With Acute Aortic Dissection

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04251247
Enrollment
159
Registered
2020-01-31
Start date
2020-03-01
Completion date
2025-01-31
Last updated
2024-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Dissection, Pulmonary Embolism

Brief summary

Acute aortic dissection is rare but potentially life-threatening disease with an incidence of 5-30 cases per million, annually. Therefore prompt diagnosis is crucial. D-dimer values have been shown to be useful in the diagnosis of acute aortic dissection. Fibrinogen levels have been shown to be low, normal or high in individuals with acute aortic dissection. This study aims to investigate whether D-dimer/fibrinogen ratio can be valuable for diagnosis of acute aortic dissection.

Interventions

DIAGNOSTIC_TESTD-dimer/fibrinogen ratio

The ratio of D-dimer (ng/ml) to fibrinogen (mg/dl)

Sponsors

Dr. Lutfi Kirdar Kartal Training and Research Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of acute aortic dissection * Diagnosis of acute pulmonary embolism * Diagnosis of non-cardiac chest pain

Exclusion criteria

* Any etiology of chest pain other than acute aortic dissection, acute pulmonary embolism, or non-cardiac chest pain * Participants who do not give consent for enrollment

Design outcomes

Primary

MeasureTime frameDescription
Acute aortic dissection24 hoursDiagnosis of acute aortic dissection confirmed by contrast enhanced computed tomography, magnetic resonance imaging, echocardiography or aortography

Countries

Turkey (Türkiye)

Contacts

Primary ContactAvni Uygar Seyhan, M.D.
uygarseyhan@gmail.com902164583000
Backup ContactAhmet Can Topcu, M.D.
ahmetcan1987@gmail.com902164583000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026